# Taysha Gene Therapies Inc. (TSHA) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$110M |
| 2024 | -$91M |
| 2023 | -$72M |
| 2022 | -$162M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$43M |
| 2025-09-30 | -$34M |
| 2025-06-30 | -$27M |
| 2025-03-31 | -$21M |
| 2024-09-30 | -$26M |
| 2024-06-30 | -$21M |
| 2024-03-31 | -$24M |
| 2023-09-30 | -$16M |
| 2023-06-30 | -$23M |
| 2023-03-31 | -$17M |

Source: [CompaniesByCap](https://companiesbycap.com/company/TSHA/operating-income)